Epstein-Barr virus-derived vector suitable for long-term expression in neurons
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (15H04281, 16H01630, 16K14589, JP24500400)
- National Institute of Advanced Industrial Science and Technology
This publication has 21 references indexed in Scilit:
- Transfection Techniques for Neuronal Cells: Table 1.Journal of Neuroscience, 2010
- Development of a Hybrid Baculoviral Vector for Sustained Transgene ExpressionMolecular Therapy, 2009
- Advances in High-capacity Extrachromosomal Vector Technology: Episomal Maintenance, Vector Delivery, and Transgene ExpressionMolecular Therapy, 2008
- Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitroVirology, 2008
- Visualization of episomal and integrated Epstein‐Barr virus DNA by fiber fluorescence in situ hybridizationInternational Journal of Cancer, 2005
- Diminished Neuronal Activity Increases Neuron-Neuron Connectivity Underlying Silent Synapse Formation and the Rapid Conversion of Silent to Functional SynapsesThe Journal of Neuroscience, 2005
- Viral vectors for gene delivery to the nervous systemNature Reviews Neuroscience, 2003
- Subunit-Specific Rules Governing AMPA Receptor Trafficking to Synapses in Hippocampal Pyramidal NeuronsCell, 2001
- Construction of Epstein–Barr Virus-Based Expression Vector Containing Mini-OriPBiochemical and Biophysical Research Communications, 1999
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985